OptiBiotix Health Plc (LON:OPTI) focuses on managing and treating widespread, chronic medical conditions, such as obesity and high cholesterol, through the modulation of the human microbiome.
14 Mar 2018
Capital Network: Optibiotix Health - Microbiome Specialist Entering Commercial Phase
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Capital Network: Optibiotix Health - Microbiome Specialist Entering Commercial Phase
OptiBiotix Health PLC (OPTI:LON) | 20.5 -0.1 (-2.4%) | Mkt Cap: 18.7m
- Published:
14 Mar 2018 -
Author:
Dr. Riccardo Lowi -
Pages:
6
OptiBiotix Health Plc (LON:OPTI) focuses on managing and treating widespread, chronic medical conditions, such as obesity and high cholesterol, through the modulation of the human microbiome.